Prospects of antigen-specific therapy in type 1 diabetes mellitus
Type 1 diabetes mellitus is commonly recognized as an autoimmune disease characterized by progressive destruction of pancreatic ?-beta-cells. Progress in diagnostics at preclinical stage is accompanied with active development of preventive measures. So far, there are no specific therapeutic agents a...
Guardado en:
Autores principales: | Tatiana Vasil'evna Nikonova, Yulia Viktorovna Alekseeva |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dcc7b58ce30f498f8bd52c9a5e94510c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Production and immune response of recombinant Hsp60 and Hsp70 from the salmon pathogen Piscirickettsia salmonis
por: WILHELM,VIVIAN, et al.
Publicado: (2005) -
Morphological Alterations and Stress Protein Variations in Lung Biopsies Obtained from Autopsies of COVID-19 Subjects
por: Rosario Barone, et al.
Publicado: (2021) -
Functional activity and peripheral insulin resistance in patients with different types of onset of diabetes mellitus
por: Tatiana Vasil'evna Nikonova, et al.
Publicado: (2012) -
Antibody Binding Alters the Characteristics and Contents of Extracellular Vesicles Released by <named-content content-type="genus-species">Histoplasma capsulatum</named-content>
por: Ludmila Matos Baltazar, et al.
Publicado: (2016) -
Detection of antihuman HSP60 antibody in patients with type 1 diabetes
por: A Mostafa Zadeh, et al.
Publicado: (2003)